Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice.
BACKGROUND: Cardiac cell death and generation of oxidative stress contribute to doxorubicin (DOX)-induced cardiac dysfunction. E3 ligase Nrdp1 plays a critical role in the regulation of cell apoptosis, inflammation and production of reactive oxygen species (ROS), which may contribute to heart failur...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3124482?pdf=render |
id |
doaj-6810fe7f6e3846c283da4b50e8dd4e2b |
---|---|
record_format |
Article |
spelling |
doaj-6810fe7f6e3846c283da4b50e8dd4e2b2020-11-25T01:00:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0166e2110410.1371/journal.pone.0021104Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice.Yuan ZhangYu-Ming KangCui TianYong ZengLi-Xin JiaXu MaJie DuHui-Hua LiBACKGROUND: Cardiac cell death and generation of oxidative stress contribute to doxorubicin (DOX)-induced cardiac dysfunction. E3 ligase Nrdp1 plays a critical role in the regulation of cell apoptosis, inflammation and production of reactive oxygen species (ROS), which may contribute to heart failure. However, the role of Nrdp1 in DOX-induced cardiac injury remains to be determined. METHODS AND RESULTS: We examined the effect of Nrdp1 overexpression with DOX treatment in rat neonatal cardiomyocytes and mouse heart tissue. Cardiomyocytes were infected with adenovirus containing GFP (Ad-GFP), Nrdp1 wild-type (Ad-Nrdp1) or the dominant-negative form of Nrdp1 (Ad-Dn-Nrdp1), then treated with DOX for 24 hr. DOX treatment increased cell death and apoptosis, with Ad-Nrdp1 infection enhancing these actions but Ad-Dn-Nrdp1 infection attenuating these effects. Furthermore, 5 days after a single injection of DOX (20 mg/kg, intraperitoneally), Nrdp1 transgenic mice (TG) showed decreased cardiac function and increased apoptosis, autophagy and oxidative stress as compared with wild-type (WT) mice (P<0.01). Survival rate was significantly lower in Nrdp1 TG mice than in WT mice 10 days after DOX injection (P<0.01). CONCLUSIONS/SIGNIFICANCE: These results were associated with decreased activation of Akt, extracellular signal-regulated kinase 1/2 (ERK1/2) and signal transducer and activator of transcription 3 (STAT3) signaling pathways. Nrdp1 may be a key mediator in the development of cardiac dysfunction after DOX treatment and associated with inhibition of Akt, ERK1/2 and STAT3. Nrdp1 may be a new therapeutic target in protecting against the cardiotoxic effects of DOX.http://europepmc.org/articles/PMC3124482?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yuan Zhang Yu-Ming Kang Cui Tian Yong Zeng Li-Xin Jia Xu Ma Jie Du Hui-Hua Li |
spellingShingle |
Yuan Zhang Yu-Ming Kang Cui Tian Yong Zeng Li-Xin Jia Xu Ma Jie Du Hui-Hua Li Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice. PLoS ONE |
author_facet |
Yuan Zhang Yu-Ming Kang Cui Tian Yong Zeng Li-Xin Jia Xu Ma Jie Du Hui-Hua Li |
author_sort |
Yuan Zhang |
title |
Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice. |
title_short |
Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice. |
title_full |
Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice. |
title_fullStr |
Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice. |
title_full_unstemmed |
Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice. |
title_sort |
overexpression of nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2011-01-01 |
description |
BACKGROUND: Cardiac cell death and generation of oxidative stress contribute to doxorubicin (DOX)-induced cardiac dysfunction. E3 ligase Nrdp1 plays a critical role in the regulation of cell apoptosis, inflammation and production of reactive oxygen species (ROS), which may contribute to heart failure. However, the role of Nrdp1 in DOX-induced cardiac injury remains to be determined. METHODS AND RESULTS: We examined the effect of Nrdp1 overexpression with DOX treatment in rat neonatal cardiomyocytes and mouse heart tissue. Cardiomyocytes were infected with adenovirus containing GFP (Ad-GFP), Nrdp1 wild-type (Ad-Nrdp1) or the dominant-negative form of Nrdp1 (Ad-Dn-Nrdp1), then treated with DOX for 24 hr. DOX treatment increased cell death and apoptosis, with Ad-Nrdp1 infection enhancing these actions but Ad-Dn-Nrdp1 infection attenuating these effects. Furthermore, 5 days after a single injection of DOX (20 mg/kg, intraperitoneally), Nrdp1 transgenic mice (TG) showed decreased cardiac function and increased apoptosis, autophagy and oxidative stress as compared with wild-type (WT) mice (P<0.01). Survival rate was significantly lower in Nrdp1 TG mice than in WT mice 10 days after DOX injection (P<0.01). CONCLUSIONS/SIGNIFICANCE: These results were associated with decreased activation of Akt, extracellular signal-regulated kinase 1/2 (ERK1/2) and signal transducer and activator of transcription 3 (STAT3) signaling pathways. Nrdp1 may be a key mediator in the development of cardiac dysfunction after DOX treatment and associated with inhibition of Akt, ERK1/2 and STAT3. Nrdp1 may be a new therapeutic target in protecting against the cardiotoxic effects of DOX. |
url |
http://europepmc.org/articles/PMC3124482?pdf=render |
work_keys_str_mv |
AT yuanzhang overexpressionofnrdp1intheheartexacerbatesdoxorubicininducedcardiacdysfunctioninmice AT yumingkang overexpressionofnrdp1intheheartexacerbatesdoxorubicininducedcardiacdysfunctioninmice AT cuitian overexpressionofnrdp1intheheartexacerbatesdoxorubicininducedcardiacdysfunctioninmice AT yongzeng overexpressionofnrdp1intheheartexacerbatesdoxorubicininducedcardiacdysfunctioninmice AT lixinjia overexpressionofnrdp1intheheartexacerbatesdoxorubicininducedcardiacdysfunctioninmice AT xuma overexpressionofnrdp1intheheartexacerbatesdoxorubicininducedcardiacdysfunctioninmice AT jiedu overexpressionofnrdp1intheheartexacerbatesdoxorubicininducedcardiacdysfunctioninmice AT huihuali overexpressionofnrdp1intheheartexacerbatesdoxorubicininducedcardiacdysfunctioninmice |
_version_ |
1725214834374475776 |